Generation and characterization of p53 null transformed hepatic progenitor cells: oval cells give rise to hepatocellular carcinoma.

Oval cells are bipotential liver stem cells able to differentiate into hepatocytes and bile duct epithelia. In normal adult liver oval cells are quiescent, existing in low numbers around the periportal region, and proliferate following severe, prolonged liver trauma. There is evidence implicating oval cells in the development of hepatocellular carcinoma, and hence the availability of an immortalized oval cell line would be invaluable for the study of liver cell lineage differentiation and carcinogenesis. A novel approach in the generation of cell lines is the use of the p53 knockout mouse. Absence of p53 allows a cell to cycle past the normal Hayflick limit, rendering it immortalized, although subsequent genetic alterations are thought necessary for transformation. p53 knockout mice were fed a choline-deficient, ethionine-supplemented diet, previously shown to increase oval cell numbers in wild-type mice. The oval cells were isolated by centrifugal elutriation and maintained in culture. Colonies of hepatic cells were isolated and characterized with respect to phenotype, growth characteristics and tumorigenicity. Analysis of gene expression by Northern blotting and immunocytochemistry suggests they are oval-like cells by virtue of albumin and transferrin expression, as well as the oval cell markers alpha fetoprotein, M(2)-pyruvate kinase and A6. Injection into athymic nude mice shows the cell lines are capable of forming tumors which phenotypically resemble hepatocellular carcinoma. Thus, the use of p53 null hepatic cells successfully generated immortalized and tumorigenic hepatic stem cell lines. The results presented support the idea that deleting p53 allows immortalization and contributes to the transformation of the oval-like cell lines. Further, the tumorigenic status of the cell lines is direct evidence for the participation of oval cells in the formation of hepatocellular carcinoma.

[1]  G. Yeoh,et al.  A modified choline‐deficient, ethionine‐supplemented diet protocol effectively induces oval cells in mouse liver , 2001, Hepatology.

[2]  D. Hanahan Cancer: Benefits of bad telomeres , 2000, Nature.

[3]  B. Portmann,et al.  The canals of hering and hepatic stem cells in humans , 1999, Hepatology.

[4]  J. Olynyk,et al.  Oval cell numbers in human chronic liver diseases are directly related to disease severity. , 1999, The American journal of pathology.

[5]  G. Yeoh,et al.  The oval-shaped cell as a candidate for a liver stem cell in embryonic, neonatal and precancerous liver: identification based on morphology and immunohistochemical staining for albumin and pyruvate kinase isoenzyme expression , 1997, Histochemistry and Cell Biology.

[6]  J. R. Smith,et al.  Mutant p53 rescues human diploid cells from senescence without inhibiting the induction of SDI1/WAF1. , 1995, Cancer research.

[7]  津熊 秀明 Risk factors for hepatocellular carcinoma among patients with chronic liver disease , 1995 .

[8]  G. Yeoh,et al.  Differentiation of oval cells into duct-like cells in preneoplastic liver of rats placed on a choline-deficient diet supplemented with ethionine. , 1994, Carcinogenesis.

[9]  J. Bond,et al.  Escape from senescence in human diploid fibroblasts induced directly by mutant p53. , 1994, Oncogene.

[10]  C. Harley,et al.  Stabilization of short telomeres and telomerase activity accompany immortalization of Epstein-Barr virus-transformed human B lymphocytes , 1994, Journal of virology.

[11]  J. R. Smith,et al.  Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. , 1994, Experimental cell research.

[12]  R. Weinberg,et al.  Tumor spectrum analysis in p53-mutant mice , 1994, Current Biology.

[13]  T. Yagi,et al.  Enhanced proliferative potential in culture of cells from p53-deficient mice. , 1993, Oncogene.

[14]  J. Trent,et al.  WAF1, a potential mediator of p53 tumor suppression , 1993, Cell.

[15]  S. Elledge,et al.  The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases , 1993, Cell.

[16]  G. Schutz,et al.  Isolation of the gene for murine glucose-6-phosphatase, the enzyme deficient in glycogen storage disease type 1A. , 1993, The Journal of biological chemistry.

[17]  L. Donehower,et al.  In vitro growth characteristics of embryo fibroblasts isolated from p53-deficient mice. , 1993, Oncogene.

[18]  H. Tsukuma,et al.  Risk factors for hepatocellular carcinoma among patients with chronic liver disease. , 1993, The New England journal of medicine.

[19]  F. Oesch,et al.  Isolation, biochemical characterization, long-term culture, and phenotype modulation of oval cells from carcinogen-fed rats. , 1993, Experimental cell research.

[20]  J. Shay,et al.  E6 of human papillomavirus type 16 can overcome the M1 stage of immortalization in human mammary epithelial cells but not in human fibroblasts. , 1993, Oncogene.

[21]  P. Brissot,et al.  Primary liver cancer in genetic hemochromatosis: a clinical, pathological, and pathogenetic study of 54 cases. , 1993, Gastroenterology.

[22]  V. Factor,et al.  Oval cells--hepatocytes relationships in Dipin-induced hepatocarcinogenesis in mice. , 1993, Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie.

[23]  Thea D. Tlsty,et al.  Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53 , 1992, Cell.

[24]  D. Denhardt,et al.  p53 mutations in spontaneously immortalized 3T12 but not 3T3 mouse embryo cells. , 1992, Oncogene.

[25]  G. Yeoh,et al.  Expression of glutathione S-transferase during rat liver development. , 1992, The Biochemical journal.

[26]  A. Levine,et al.  p53 alteration is a common event in the spontaneous immortalization of primary BALB/c murine embryo fibroblasts. , 1991, Genes & development.

[27]  K. Zaret,et al.  Hepatocyte differentiation initiates during endodermal-mesenchymal interactions prior to liver formation. , 1991, Development.

[28]  J. Shay,et al.  A role for both RB and p53 in the regulation of human cellular senescence. , 1991, Experimental cell research.

[29]  J. Lemire,et al.  Oval cell proliferation and the origin of small hepatocytes in liver injury induced by D-galactosamine. , 1991, The American journal of pathology.

[30]  S. Fletcher,et al.  Gene expression in clonally derived cell lines produced by in vitro transformation of rat fetal hepatocytes: isolation of cell lines which retain liver-specific markers. , 1990, Cancer research.

[31]  V. Factor,et al.  Common antigens of mouse oval and biliary epithelial cells. Expression on newly formed hepatocytes. , 1990, Differentiation; research in biological diversity.

[32]  F. Bosch,et al.  Two genetically defined trans-acting loci coordinately regulate overlapping sets of liver-specific genes , 1990, Cell.

[33]  S. Sell,et al.  Evidence for the stem cell origin of hepatocellular carcinoma and cholangiocarcinoma. , 1989, The American journal of pathology.

[34]  A. Hall,et al.  p21H‐ras‐induced morphological transformation and increases in c‐myc expression are independent of functional protein kinase C. , 1989, The EMBO journal.

[35]  S. Thorgeirsson,et al.  In vivo differentiation of rat liver oval cells into hepatocytes. , 1989, Cancer research.

[36]  N. Marceau,et al.  Biliary epithelial and hepatocytic cell lineage relationships in embryonic rat liver as determined by the differential expression of cytokeratins, alpha-fetoprotein, albumin, and cell surface-exposed components. , 1988, Cancer research.

[37]  N. Marceau,et al.  Promotion of growth and differentiation of rat ductular oval cells in primary culture. , 1988, Cancer research.

[38]  P. Prior Long-term cancer risk in alcoholism. , 1988, Alcohol and alcoholism.

[39]  S. Thorgeirsson,et al.  A precursor-product relationship exists between oval cells and hepatocytes in rat liver. , 1987, Carcinogenesis.

[40]  N. Thompson,et al.  Growth in culture and tumorigenicity after transfection with the ras oncogene of liver epithelial cells from carcinogen-treated rats. , 1987, Cancer research.

[41]  A. Geiser,et al.  Suppression of tumorigenicity with continued expression of the c-Ha-ras oncogene in EJ bladder carcinoma-human fibroblast hybrid cells. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[42]  H. Dahl,et al.  Isolation and sequence of a cDNA clone which contains the complete coding region of rat phenylalanine hydroxylase. Structural homology with tyrosine hydroxylase, glucocorticoid regulation, and use of alternate polyadenylation sites. , 1986, The Journal of biological chemistry.

[43]  M. Rissel,et al.  A procedure for light and electron microscopic intracellular immunolocalization of collagen and fibronectin in rat liver. , 1985, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[44]  P. Yaswen,et al.  Expression of c-Ki-ras, c-Ha-ras, and c-myc in specific cell types during hepatocarcinogenesis , 1985, Molecular and cellular biology.

[45]  C. Dani,et al.  Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate-dehydrogenase multigenic family. , 1985, Nucleic acids research.

[46]  Synthesis of rat transferrin in Escherichia coli containing a recombinant bacteriophage. , 1984, Biochemical and biophysical research communications.

[47]  P. Yaswen,et al.  Isolation of oval cells by centrifugal elutriation and comparison with other cell types purified from normal and preneoplastic livers. , 1984, Cancer research.

[48]  J. Marie,et al.  Molecular cloning of cDNA for rat L-type pyruvate kinase and aldolase B. , 1983, The Journal of biological chemistry.

[49]  Robert A. Weinberg,et al.  Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes , 1983, Nature.

[50]  G. Schütz,et al.  Isolation of cDNA clones coding for rat tyrosine aminotransferase. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[51]  Benjamin Geiger,et al.  The catalog of human cytokeratins: Patterns of expression in normal epithelia, tumors and cultured cells , 1982, Cell.

[52]  L. Jagodzinski,et al.  Fine structure and evolution of the rat serum albumin gene , 1981, Molecular and cellular biology.

[53]  L. Jagodzinski,et al.  Sequence homology between RNAs encoding rat alpha-fetoprotein and rat serum albumin. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[54]  S. Sell,et al.  Early histological and functional alterations of ethionine liver carcinogenesis in rats fed a choline-deficient diet. , 1978, Cancer research.

[55]  H. Boedtker,et al.  RNA molecular weight determinations by gel electrophoresis under denaturing conditions, a critical reexamination. , 1977, Biochemistry.

[56]  R. Kuchler Biochemical methods in cell culture and virology , 1977 .

[57]  P. Seglen Preparation of rat liver cells. II. Effects of ions and chelators on tissue dispersion. , 1973, Experimental cell research.

[58]  P. Seglen Preparation of rat liver cells. I. Effect of Ca 2+ on enzymatic dispersion of isolated, perfused liver. , 1972, Experimental cell research.

[59]  R. Hinegardner,et al.  An improved fluorometric assay for DNA. , 1971, Analytical biochemistry.

[60]  L. Hayflick,et al.  The serial cultivation of human diploid cell strains. , 1961, Experimental cell research.